Loading Events

Breaking Barriers in Alzheimer’s Disease: Perspectives on Early Stage Alzheimer’s

  • This event has passed.

April 26, 2024 @ 12:00 pm - 12:30 pm EDT

Approximately two-thirds of Alzheimer’s disease patients are women, as well as more than 60% of their caregivers. Stigma surrounding Alzheimer’s and dementia can cause some women to dismiss symptoms as normal aging or menopausal brain fog and delay talking to their health care provider. Moreover, coverage of screening and diagnostic tests can be difficult and confusing to navigate, also contributing to delays in diagnosing and treating Alzheimer’s. 

An early diagnosis is essential for slowing the progression of Alzheimer’s disease, planning for long-term care, and maintaining quality of life for both patients and their caregivers. It also provides more opportunities for individuals to participate in medical decisions and potential clinical trials, as well as maintain meaningful social relationships within their community. 

Researchers are continuing to investigate more cost-effective and noninvasive approaches for diagnosing Alzheimer’s disease and related dementias. Coupling education to innovation broadens awareness and helps women make informed decisions about their health care throughout their Alzheimer’s journey. 

SWHR is hosting a series of webinars to share the experiences of women with Alzheimer’s disease and highlight the importance of access to innovative diagnostics throughout the diagnostic journey. 

The SWHR Breaking Barriers in Alzheimer’s Disease series includes: 

  • Perspectives on Early Stage Alzheimer’s (April 26, 2024) 
  • Innovative Diagnostics for Women (June 2024) 
  • A Congressional Briefing (Sept 2024) 
  • Policy Actions for Improving Women’s Health (Nov 2024)


April 26, 2024
12:00 pm - 12:30 pm EDT
Event Categories:
, , ,




  • Highlight the impacts of Alzheimer’s disease on women’s health
  • Increase visibility of the patient experience, with special emphasis on living with an early onset diagnosis
  • Empower women and their communities to improve quality of care and general well-being for those living with Alzheimer’s disease

Are you interested in seeing more of this type of educational programming on women’s health from SWHR?

Donate Today


Jackie Torfin, MT(ASCP) 


Jackie Torfin, MT(ASCP) 


Jackie Torfin is the CEO and Principal Advisor at QLeaR Advisors. She has been a leader in MedTech and Biotech companies for 30+ years. She has had roles in quality, regulatory, pre-clinical and clinical compliance. She has a BS in Medical Technology, a Master’s in Leadership, and has been Adjunct Faculty for 11 years at St. Cloud University in the Master’s in Medical Technology Quality and Regulatory Science Programs.  

Jackie is CEO and Principal Advisor at QLeaR Advisors, a consulting firm focused on quality and regulatory compliance for MedTech and Biotech companies. She supports start-ups and emerging clients in understanding and being compliant to the maze of regulations.  

When not working, she and her husband and two dogs enjoy spending time at their cabin in northern Minnesota and with their family of six children and six grandchildren.   


Support for this educational program has been provided by Eli Lilly & Co. SWHR maintains independence and editorial control over program development, content, and work products.

Lilly Logo